CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 208 enrolled
Drug / intervention
Whey protein supplement +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00421408
NCT00421408Phase 2Completed
CompareCT.gov

Impact of a Protein Supplement on Bone Mass in Older Men and Women

Yale University·interventional·Posted Jan 12, 2007·Updated Apr 9, 2020

In Brief

A Phase 2 clinical trial evaluating Whey protein supplement and Placebo for Bone Resorption and Osteoporosis. Completed, enrolled 208 participants across 2 sites.

Detailed Summary

Women and men consuming a low protein diet may be at risk for bone loss. The purpose of this study is to determine whether a daily protein supplement will improve bone health among healthy older adults.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBone Resorption, Osteoporosis
CountriesUnited States
CollaboratorsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Office of Dietary Supplements (ODS)

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 12, 2007
Enrollment StartFeb 1, 2007
Primary CompletionMay 1, 2012
Study CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 19.5 years ago

Interventions

Whey protein supplementdietary

40-g whey protein supplement daily for 18 months

Placebodietary

Placebo supplement daily for 18 months